Seoulin Bioscience Co.,Ltd. (KOSDAQ:038070)

Seoulin Bioscience Revenue

Seoulin Bioscience had revenue of 19.53B KRW in the quarter ending March 31, 2026, with 8.28% growth. This brings the company's revenue in the last twelve months to 78.58B, up 5.38% year-over-year. In the year 2025, Seoulin Bioscience had annual revenue of 77.09B with 2.23% growth.

• Revenue (ttm): 78.58B
• Revenue Growth: +5.38%
• P/S Ratio: 0.57
• Revenue / Employee: 755.62M
• Employees: 104
• Market Cap: 44.71B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	77.09B	1.68B	2.23%
Dec 31, 2024	75.41B	-14.16B	-15.81%
Dec 31, 2023	89.57B	-15.14B	-14.46%
Dec 31, 2022	104.71B	24.17B	30.01%
Dec 31, 2021	80.54B	15.45B	23.74%

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jun 17, 2026

Data Sources Report a data error